Skip to main content
. 2022 Mar 2;12(3):210320. doi: 10.1098/rsob.210320

Figure 2.

Figure 2.

HCV antigen-specific lysis of A0201 B cell targets by KLVALGINAV CD8+ T cell clone SR01-78 from an individual with spontaneous resolved HCV. (a) Schematic detailing exogenous peptide pulsing of liver cells and stimulation of T cells. (b) Sorting strategy for HCV tetramer positive CD8+ T cells. (c) Chromium release assay demonstrating antigen-specific lysis of A0201 class I MHC transfected B cell (721.221) exogenously loaded peptide targets (KLVALGINAV and control peptide) and endogenously synthesized antigen targets (vvNS3 and control vvWT) at effector to target ratios of 20 : 1, 5 : 1 and 1 : 1.